Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
LMDXW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.21
N/A
NA
vs NA
Q2.21
N/A
NA
vs NA
Q3.21
N/A
NA
vs NA
Q4.21
N/A
NA
vs NA
Q1.22
N/A
NA
vs NA
Q2.22
N/A
NA
vs NA
Q3.22
N/A
NA
vs NA
Q4.22
N/A
NA
vs NA
Q1.23
N/A
NA
vs NA
Q2.23
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q1.21
+207%
106.9M vs 34.8M
Q2.21
+151%
87.2M vs 34.8M
Q3.21
+683%
109.1M vs 13.9M
Q4.21
+5%
118.3M vs 112.3M
Q1.22
+18%
126.4M vs 106.9M
Q2.22
-49%
44.7M vs 87.2M
Q3.22
-61%
42.2M vs 109.1M
Q4.22
-65%
41.1M vs 118.3M
Q1.23
-82%
22.2M vs 126.4M
Q2.23
-53%
21M vs 44.7M
Return on Equity
QoQ
Q3.21
+46%
0.46
vs -0.38
Q4.21
-23%
-0.23
vs 0.46
Q1.22
-45%
-0.45
vs -0.23
Q2.22
-932%
-9.32
vs -0.45
Q3.22
-793%
-7.93
vs -9.32
Q4.22
+91%
0.91
vs -7.93
Q1.23
+29%
0.29
vs 0.91
Q2.23
+23%
0.23
vs 0.29
Institutionnal Ownership
QoQ
Q4.22
18
18
vs 24
-25%
Q1.23
18
18
vs 18
NA
Q2.23
19
19
vs 18
6%
Q3.23
18
18
vs 19
-5%
Q4.23
16
16
vs 18
-11%
Q1.24
3
3
vs 16
-81%
Q2.24
2
2
vs 3
-33%
Q3.24
1
1
vs 2
-50%
Quote Panel
Key Metrics
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
LMDXW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
NASDAQ
Relative Strenght
0
Volume Buzz
0%
Earning Acce
No
Dist 52w H.
29%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How LMDXW compares to sector?